FDA Device Intelligence
HomeVentana Medical Systems, Inc. › VENTANA PD-L1 (SP263) Assay

VENTANA PD-L1 (SP263) Assay

Ventana Medical Systems, Inc. · Model 50 test · UDI-DI 04015630972784

PLS Prescription
0
510(k) clearances
35
Adverse events
2
Recalls
4
Facilities

Recalls

DateFirmReason
2022-11-18Ventana Medical Systems, Inc.Internal comparison studies revealed unacceptable, light staining. Light staining affects the borderline of positive versus negative test results. It can cause a reduction in both
2018-02-02Dako North America Inc.To correct the kit's instructions for use as the storage time for gastric and gastroesophageal junction adenocarcinoma cut sections will be changed from six months to five months.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.